680613-09-6Relevant academic research and scientific papers
Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors
Bergan, Raymond,Clutter, Matthew R.,Deibler, Kristine K.,Fowler, Graham,George, Mariam Donny,Gordon, Ryan,Mishra, Rama K.,O'Connor, Matthew,Scheidt, Karl A.,Schiltz, Gary E.,Vagadia, Purav P.
, p. 615 - 620 (2019/02/25)
Herein we report the discovery of a novel series of highly potent and selective mitogen-activated protein kinase kinase 4 (MEK4) inhibitors. MEK4 is an upstream kinase in MAPK signaling pathways that phosphorylates p38 MAPK and JNK in response to mitogenic and cellular stress queues. MEK4 is overexpressed and induces metastasis in advanced prostate cancer lesions. However, the value of MEK4 as an oncology target has not been pharmacologically validated because selective chemical probes targeting MEK4 have not been developed. Optimization of this series via structure–activity relationships and molecular modeling led to the identification of compound 6 ff (4-(6-fluoro-2H-indazol-3-yl)benzoic acid), a highly potent and selective MEK4 inhibitor. This series of inhibitors is the first of its kind in both activity and selectivity and will be useful in further defining the role of MEK4 in prostate and other cancers.
SUBSTITUTED 4-(INDAZOL-3-YL)PHENOLS AS ESTROGEN RECEPTOR (ER) LIGANDS AND THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES
-
Page 107, (2008/06/13)
This invention provides compound of formulae I or II having the structure wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined in the specification or a pharmaceutically acceptable salt thereof which are useful for the treatment of the infla
